martes, 1 de septiembre de 2026

5 burning questions on Trump’s latest deals with drugmakers Agreements leave open questions for patients, companies, and policymakers alike By Daniel Payne, Elaine Chen, and John WilkersonSept. 1, 2026

https://www.statnews.com/2026/09/01/trump-pharma-deals-analysis-latest-round-most-favored-nation-drug-pricing/

No hay comentarios:

Publicar un comentario